Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT06256484 |
| Title | A Study to Evaluate the Safety and Preliminary Efficacy of ATA3219 in Participants With Relapsed/Refractory B-cell Non-Hodgkin Lymphoma |
| Recruitment | Recruiting |
| Gender | both |
| Phase | Phase I |
| Variant Requirements | No |
| Sponsors | Atara Biotherapeutics |
| Indications | |
| Therapies | |
| Age Groups: | adult | senior |
| Covered Countries | USA | AUS |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| AdventHealth Cancer Institute | ACTIVE_NOT_RECRUITING | Orlando | Florida | 32804 | United States | Details |
| Norton Cancer Institute - Saint Matthews | ACTIVE_NOT_RECRUITING | Louisville | Kentucky | 40207 | United States | Details |
| Sidney Kimmel Cancer Center - Jefferson Health | ACTIVE_NOT_RECRUITING | Philadelphia | Pennsylvania | 19107 | United States | Details |
| University of Virgina | ACTIVE_NOT_RECRUITING | Charlottesville | Virginia | 22908 | United States | Details |
| Princess Alexandra Hospital | RECRUITING | Woolloongabba | Queensland | 4102 | Australia | Details |
| Fiona Stanley Hospital | RECRUITING | Murdoch | Western Australia | 6150 | Australia | Details |